Company Filing History:
2 out of 81 
1 out of 832,843 Years Active: 1995-1998
Title: Chihiro Azuma: Pioneering Innovations in Oxytocin Receptor Research
Introduction: Chihiro Azuma, an accomplished inventor based in Osaka, Japan, has made significant contributions to the field of biochemistry through her innovative research focused on oxytocin receptors. With an impressive portfolio of three patents, Azuma has been at the forefront of developing novel approaches for understanding and utilizing the oxytocin receptor, a vital component in numerous physiological processes.
Latest Patents: Among her latest patents, Chihiro Azuma has developed groundbreaking technology related to the oxytocin receptor and DNA coding therefor. This invention encompasses a receptor responsible for the posterior pituitary hormone, oxytocin, along with a DNA sequence that encodes this receptor. Furthermore, her work involves a recombinant DNA molecule containing the DNA sequence and a transformant comprising said molecule. The implications of this invention extend into detection and diagnostic methods, as well as a corresponding kit that includes oxytocin, its receptor, or antibodies targeting the receptor.
In addition, another notable patent pertains to anti-oxytocin receptor antibodies. This invention highlights antibodies that specifically bind to either the extracellular or intracellular regions of the oxytocin receptor, as well as hybridomas that produce these antibodies. This technology offers invaluable tools for the immunodetection and immunopurification of oxytocin receptor polypeptides.
Career Highlights: Chihiro Azuma has worked with reputable organizations, including Rohto Pharmaceutical Co., Ltd., where she honed her expertise in pharmaceutical innovations and research applications. Her tenacity and dedication to advancement in her field have led to the development of technologies that have the potential to revolutionize the understanding and treatment of various medical conditions associated with oxytocin.
Collaborations: Throughout her career, Azuma has collaborated with notable colleagues such as Fumitaka Saji and Tadashi Kimura. These collaborations have facilitated the exchange of ideas and accelerated the development of innovative solutions to complex scientific challenges.
Conclusion: Chihiro Azuma exemplifies the spirit of innovation, as evidenced by her impactful contributions to the study of oxytocin receptors. Her patents not only enhance scientific understanding but also pave the way for potential therapeutic applications in the medical field. With her combined expertise and collaborative spirit, the future prospects of her ongoing research are poised to make a lasting impact.